Top

Reactions Weekly

Published in:

01-06-2023 | Lymphedema | Case report

Talimogene laherparepvec

Worsening of a chronic lymphedema of the leg and superficial ulceration in the area of the injections: 2 case reports

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Kleemann J, et al. Real-world experience of talimogene laherparepvec (T-vec) in old and oldest-old patients with melanoma: A retrospective single center study. Cancer Management and Research 13: 5699-5709, 15 Jul 2021. Available from: URL: http://doi.org/10.2147/CMAR.S286917

Title: Talimogene laherparepvec
Worsening of a chronic lymphedema of the leg and superficial ulceration in the area of the injections: 2 case reports
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Lymphedema
Melanoma
Melanoma
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-42038-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Talimogene laherparepvec

Worsening of a chronic lymphedema of the leg and superficial ulceration in the area of the injections: 2 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Multiple drugs

Antineoplastics

Immunosuppressants/immune-globulin

Antithymocyte-globulin

Epinephrine/sugammadex

PI updates for ceftriaxone, flucloxacillin, teicoplanin, tofacitinib